<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02822053</url>
  </required_header>
  <id_info>
    <org_study_id>LA-002</org_study_id>
    <nct_id>NCT02822053</nct_id>
  </id_info>
  <brief_title>Effectivity and Safety of Ultrasound-guided Percutaneously Laser Ablation for Refractory Neoplasms</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>First Affiliated Hospital of Zhejiang University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>First Affiliated Hospital of Zhejiang University</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the safety and efficacy of ultrasonography (US)
      -guided laser ablation liver, kidney, pancreas, lung and retroperitoneal tumors, the
      investigators used preoperative and postoperative US/CEUS/CT/MRI to assess lesions, and
      laboratory tests including the tumor markers to evaluate the general condition of patients.
      Intraoperative US/CEUS/CT would be applied to monitor ablation lesions.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2016</start_date>
  <completion_date type="Anticipated">June 2018</completion_date>
  <primary_completion_date type="Anticipated">June 2018</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>100 patients of refractory neoplasms with image-guided laser ablation-related effectivity as assessed by MRI</measure>
    <time_frame>up to 24 months</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Refractory Neoplasms</condition>
  <arm_group>
    <arm_group_label>US-guided laser ablation for refractory neoplasms</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The investigators used percutaneously US-guided laser ablation for patients with small hepatocellular carcinoma (single or multiple nodules of less than 3 cm in diameter), Child-Pugh A/B, PLT ≥ 50*10E9/L and PT ≤ 20s. Then the investigators estimated the safety and efficacy of this treatment through follow-up of US/CEUS/CT/MRI and the tumor markers every three months.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>US-guided laser ablation for refractory neoplasms</intervention_name>
    <arm_group_label>US-guided laser ablation for refractory neoplasms</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with small hepatocellular carcinoma (single or multiple nodules of less than
             3 cm in diameter),

          -  Patients with Child-Pugh A/B,

          -  Patients with PLT ≥ 50*10E9/L and PT ≤ 20s.

        Exclusion Criteria:

          -  Patients with blood coagulation dysfunction, ChildPugh ≥3, severe cardiopulmonary
             disease, intolerant anesthesia and upper gastrointestinal bleeding in shock.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Tian'an Jiang, Phd</last_name>
    <phone>+86 18857127666</phone>
    <email>tiananjiang@126.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Guo Tian, Master</last_name>
    <phone>+86 13600529967</phone>
    <email>871035504@qq.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>The First Affiliated Hospital of Zhejiang University</name>
      <address>
        <city>Hangzhou</city>
        <state>Zhejiang</state>
        <zip>310003</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tian'an Jiang, Phd</last_name>
      <phone>+86 18857127666</phone>
      <email>tiananjiang@126.com</email>
    </contact>
    <contact_backup>
      <last_name>Guo Tian, Master</last_name>
      <phone>+86 13600529967</phone>
      <email>871035504@qq.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <results_reference>
    <citation>Francica G, Petrolati A, Di Stasio E, Pacella S, Stasi R, Pacella CM. Influence of ablative margin on local tumor progression and survival in patients with HCC ≤4 cm after laser ablation. Acta Radiol. 2012 May 1;53(4):394-400. doi: 10.1258/ar.2012.110471. Epub 2012 Mar 5.</citation>
    <PMID>22393158</PMID>
  </results_reference>
  <results_reference>
    <citation>Wu X, Zhou P, Ma S, Tian S, Deng J, Zhao Y. [Ultrasound-guided laser thermal ablation for treatment of small liver cancer at high-risk sites]. Nan Fang Yi Ke Da Xue Xue Bao. 2016 Jan;36(1):120-5. Chinese.</citation>
    <PMID>26806751</PMID>
  </results_reference>
  <results_reference>
    <citation>Di Costanzo GG, D'Adamo G, Tortora R, Zanfardino F, Mattera S, Francica G, Pacella CM. A novel needle guide system to perform percutaneous laser ablation of liver tumors using the multifiber technique. Acta Radiol. 2013 Oct;54(8):876-81. doi: 10.1177/0284185113489825. Epub 2013 May 23.</citation>
    <PMID>23761559</PMID>
  </results_reference>
  <results_reference>
    <citation>Zou X, Liu Q, Zhou X, He G, Yu M, Han Z, Meng X, Su H. Ultrasound-guided percutaneous laser and ethanol ablation of rabbit VX2 liver tumors. Acta Radiol. 2013 Mar 1;54(2):181-7. doi: 10.1258/ar.2012.110723.</citation>
    <PMID>23482351</PMID>
  </results_reference>
  <results_reference>
    <citation>Clements LW, Collins JA, Weis JA, Simpson AL, Adams LB, Jarnagin WR, Miga MI. Evaluation of model-based deformation correction in image-guided liver surgery via tracked intraoperative ultrasound. J Med Imaging (Bellingham). 2016 Jan;3(1):015003. doi: 10.1117/1.JMI.3.1.015003. Epub 2016 Mar 23.</citation>
    <PMID>27081664</PMID>
  </results_reference>
  <verification_date>June 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 20, 2016</study_first_submitted>
  <study_first_submitted_qc>July 1, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 4, 2016</study_first_posted>
  <last_update_submitted>July 1, 2016</last_update_submitted>
  <last_update_submitted_qc>July 1, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 4, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Ultrasonography-guided Laser Ablation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

